Plastic biochip speeds up protein detection

A new, fast, and inexpensive way to test for medically important molecules, such the blood clot protein thrombin and faulty proteins present in Alzheimer’s disease, could emerge from research published today in the journal Advanced Materials.

Mario Leclerc and his colleagues at Université Laval in Québec City, Canada, have developed a new type of sensor based on an array of DNA strands attached to a polymer film on a glass chip. When a protein sticks to this biochip DNA array, the attachment distorts the underlying polymer molecules, changing their optical properties and making them fluorescent. Their glow can then be readily measured with standard fluorescence detection techniques.

The biosensor can be built from specific DNA strands called "aptamers". These stick only to a specific protein and so can detect just a single protein, even in a mixture containing lots of other molecules that would otherwise interfere with the sensing process and give false positives. The new biochip has several other advantages over conventional protein sensors. These usually require sophisticated sample preparation and tagging the proteins with fluorescent molecules. Leclerc’s biochip works with raw samples and needs no tags to work, and can be read using conventional DNA microarray readers.

The team tested the biochip using DNA responsive to the blood clotting protein thrombin and were able to detect a few attomoles of thrombin (or 3.6 × 10^-13 g). Thrombin initiates the clotting process when you receive a cut or other injury. However, when this clotting cascade goes awry medical conditions such as thrombosis can arise. A quick and easy test for thrombin in a sample would provide medical researchers useful information in studying this and other related blood disorders.

Leclerc explains that in its present incarnation, the sensitivity of their biochip is limited by the relatively large size of the DNA spots in the array. So, he and his colleagues are currently looking at ways to make these spots much smaller (with a diameter of 100 micrometers or smaller) without reducing the biochip’s specificity for a protein of interest. He also suggests that advances in microfluidic devices, which can easily integrate sample handling and detection for very small sample volumes (on the order of a few microliters), would allow them to speed up the analysis even more.

Currently, it takes about an hour for the biochip to "develop". The integration of several biochips for fast parallel testing of different proteins may also become a reality thanks to microfluidics. "If an aptamer has been found for a given protein, in principle we will be able to detect that protein," says Leclerc, "but more testing is needed to qualify that."

Leclerc adds that the technology could be applied to a wide range of diseases involving proteins. Many diseases are attributed to conformational changes in proteins, including Alzheimer’s disease and transmissible spongiform encephalopathy, related to "mad cow disease", for instance. By combining the appropriate DNA aptamer and polymer, Leclerc says that future work could be lead to sensors for the proteins responsible for these diseases.

Citation: Mario Leclerc et al., Protein Detecting Arrays Based on Cationic Polythiophene–DNA-Aptamer Complexes, Advanced Materials 2006, 18, No. 20, 2703–2707, doi: 10.1002/adma.200601651

Source: Advanced Materials

Related stories:

Biochips can detect cancers before symptoms develop
In their fight against cancer, doctors have just gained an impressive new weapon to add to their arsenal. Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a chip that can save lives by diagnosing certain cancers even before patients become symptomatic.
Biochip allows genes to express themselves
Biochip platforms that work as artificial cells are attractive for medical diagnostics, interrogation of biological processes, and for the production of important biomolecules. However, to match the complexity of nature, the biochips need to be designed such that proteins, DNA, and other important biological components can be located in specific, spatially well-defined regions on the chips.
The pocket laboratory
Made in Germany, the world’s first fully electric biochip can quickly, reliably and automatically detect pathogens or residual traces of antibiotics. For this development, the president of the Federal Republic awarded the German Future Prize to three researchers.
Is it influenza, or only a bad cold with a fever? An instant test gives the physician the answer. He simply puts a few drops of the patient’s blood on an analyzer the size of a credit card, and just a few minutes later the doctor knows if his patient is suffering from genuine influenza. The system also tells him which medicine will be most effective for the sufferer and what the dosage should be.
Thumbs up -- a tiny ancestral remnant lends developmental edge to humans
Subtle genetic changes that confer an evolutionary advantage upon a species, such as the dexterity characteristic of the human hand, while difficult to detect and even harder to reproduce in a model system, have nevertheless generated keen interest amongst evolutionary biologists. In findings published online in the September 5 edition of the journal Science, researchers from the U.S. Department of Energy's Lawrence Berkeley National Laboratory and their collaborators, have uncovered a specifically human 13-nucelotide change concealed in the vast three-billion-letter landscape of the human genome.
Studies spot numerous undiscovered gene alterations in pancreatic and brain cancers
HHMI investigators have detected a multitude of broken, missing, and overactive genes in pancreatic and brain tumors, in the most detailed genetic survey yet of any human tumor. Some of these genetic changes were previously unknown and could provide new leads for improved diagnosis and therapy for these devastating cancers.
Molecular evolution is echoed in bat ears
Echolocation may have evolved more than once in bats, according to new research from the University of Bristol published this week in Proceedings of the National Academy of Sciences (PNAS).
Structure of key epigenetics component identified
Scientists from the Structural Genomics Consortium (SGC) have determined the 3D structure of a key protein component involved in enabling "epigenetic code" to be copied accurately from cell to cell.
DNA editing tool flips its target
Imagine having to copy an entire book by hand without missing a comma. Our cells face a similar task every time they divide. They must duplicate both their DNA and a subtle pattern of punctuation-like modifications on the DNA known as methylation.

News discussion:

Physics news